Eli Lilly & Co. (LLY)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 13, 2025

$870.36

P/E Ratio

74.43

Market Cap

$827.67B

Description
Add to research

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Metrics
Add to research

Overview

  • HQIndianapolis, IN
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerLLY
  • Price$870.36-0.13%

Trading Information

  • Market cap$827.67B
  • Float89.62%
  • Average Daily Volume (1m)3,692,926
  • Average Daily Volume (3m)3,840,258
  • EPSN/A

Company

  • Revenue$45.04B
  • Rev growth (1yr)32.00%
  • Net income$10.59B
  • Gross margin82.54%
  • EBITDA marginN/A
  • EBITDAN/A
  • EVN/A
  • EV/RevenueN/A
  • P/E74.43
  • P/S17.50
  • P/B58.18
  • Debt/EquityN/A
Documents
Add to research
Factset Street Account